Max Kaufmann

2.6k total citations · 1 hit paper
18 papers, 486 citations indexed

About

Max Kaufmann is a scholar working on Oncology, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, Max Kaufmann has authored 18 papers receiving a total of 486 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 4 papers in Genetics and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Max Kaufmann's work include Estrogen and related hormone effects (3 papers), Multiple Sclerosis Research Studies (2 papers) and Historical Geopolitical and Social Dynamics (2 papers). Max Kaufmann is often cited by papers focused on Estrogen and related hormone effects (3 papers), Multiple Sclerosis Research Studies (2 papers) and Historical Geopolitical and Social Dynamics (2 papers). Max Kaufmann collaborates with scholars based in Germany, United Kingdom and Denmark. Max Kaufmann's co-authors include Lars Fugger, Manuel A. Friese, Kathrine E. Attfield, Lise Torp Jensen, Gurman Kaur, Bernhard Lüscher, Karla L. H. Feijs, Hayley G. Evans, Anne Willing and Nina Kursawe and has published in prestigious journals such as Nature Neuroscience, Nature reviews. Immunology and Cancer.

In The Last Decade

Max Kaufmann

17 papers receiving 467 citations

Hit Papers

The immunology of multiple sclerosis 2022 2026 2023 2024 2022 50 100 150
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. The immunology of multiple sclerosis
    2022 196 citations Kathrine E. Attfield, Lise Torp Jensen et al. Nature reviews. Immunology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Max Kaufmann Germany 9 184 163 132 103 101 18 486
Vijay K. Ulaganathan Germany 7 169 0.9× 145 0.9× 113 0.9× 93 0.9× 80 0.8× 11 483
C.D. Dijkstra Netherlands 9 230 1.3× 117 0.7× 73 0.6× 58 0.6× 98 1.0× 13 495
Sunny Malhotra Spain 12 211 1.1× 257 1.6× 108 0.8× 58 0.6× 71 0.7× 26 484
Carolyn J. Hoban United States 7 152 0.8× 132 0.8× 137 1.0× 101 1.0× 74 0.7× 11 472
Friederike Frommer Germany 9 359 2.0× 138 0.8× 108 0.8× 146 1.4× 75 0.7× 9 581
Ben J. E. Raveney Japan 12 420 2.3× 184 1.1× 78 0.6× 93 0.9× 90 0.9× 21 711
Megumi Nakanishi Japan 9 109 0.6× 116 0.7× 85 0.6× 57 0.6× 56 0.6× 24 352
Kirsten Adlard United States 11 445 2.4× 71 0.4× 172 1.3× 75 0.7× 188 1.9× 13 711
Karim L. Kreft Netherlands 13 141 0.8× 104 0.6× 151 1.1× 98 1.0× 59 0.6× 24 408
Elise Tran United States 9 206 1.1× 81 0.5× 101 0.8× 102 1.0× 142 1.4× 17 594

Countries citing papers authored by Max Kaufmann

Since Specialization
Citations

This map shows the geographic impact of Max Kaufmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Max Kaufmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Max Kaufmann more than expected).

Fields of papers citing papers by Max Kaufmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Max Kaufmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Max Kaufmann. The network helps show where Max Kaufmann may publish in the future.

Co-authorship network of co-authors of Max Kaufmann

This figure shows the co-authorship network connecting the top 25 collaborators of Max Kaufmann. A scholar is included among the top collaborators of Max Kaufmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Max Kaufmann. Max Kaufmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Kaufmann, Max, Fabian Coscia, Calliope A. Dendrou, et al.. (2022). Identification of early neurodegenerative pathways in progressive multiple sclerosis. Nature Neuroscience. 25(7). 944–955. 81 indexed citations
2.
Attfield, Kathrine E., Lise Torp Jensen, Max Kaufmann, Manuel A. Friese, & Lars Fugger. (2022). The immunology of multiple sclerosis. Nature reviews. Immunology. 22(12). 734–750. 196 indexed citations breakdown →
3.
Kaufmann, Max, Hayley G. Evans, Jan Broder Engler, et al.. (2021). Identifying CNS-colonizing T cells as potential therapeutic targets to prevent progression of multiple sclerosis. Med. 2(3). 296–312.e8. 57 indexed citations
4.
Kaufmann, Max, Karla L. H. Feijs, & Bernhard Lüscher. (2014). Function and Regulation of the Mono-ADP-Ribosyltransferase ARTD10. Current topics in microbiology and immunology. 384. 167–188. 26 indexed citations
5.
Kaufmann, Max. (2012). JMaxAlign: A Maximum Entropy Parallel Sentence Alignment Tool. International Conference on Computational Linguistics. 277–288. 12 indexed citations
6.
Loibl, Sibylle, Frédéric Amant, Max Kaufmann, et al.. (2010). Abstract S6-2: 313 Patients with Breast Cancer during Pregnancy — Results from a Prospective and Retrospective Registry (GBG-20/BIG02-03). Cancer Research. 70(24_Supplement). S6–2. 10 indexed citations
7.
Kaufmann, Max. (2010). Churbn Lettland: The Destruction of the Jews of Latvia. 3 indexed citations
8.
Minckwitz, G von, G. Raab, J. Hilfrich, et al.. (2001). Präoperative Chemotherapie operabler primärer Mammakarzinome mit einer dosisdichten Kombination von Adriamycin und Docetaxel (ADoc) - Die Erfahrungen der GEPARDO-GABG-Studiengruppe -. Zentralblatt für Gynäkologie. 123(9). 497–504. 4 indexed citations
9.
Kaufmann, Max, et al.. (1999). Churbn Lettland : die Vernichtung der Juden Lettlands. 1 indexed citations
10.
Minckwitz, Gϋnter von, et al.. (1991). Hormonelle Folgetherapien nach Goserelin (Zoladex®) beim metastasierten Mammakarzinom prämenopausaler Patientinnen. Archives of Gynecology and Obstetrics. 250(1-4). 258–264. 1 indexed citations
11.
Abel, Ulrich, Nikolaus Becker, Rainer Frentzel‐Beyme, et al.. (1991). Common infections in the history of cancer patients and controls. Journal of Cancer Research and Clinical Oncology. 117(4). 339–344. 37 indexed citations
12.
Kaufmann, Max, H. Schmid, U. Raeth, et al.. (1990). Aszites-Therapie mit Tumornekrosefaktor beim Ovarialkarzinom. Geburtshilfe und Frauenheilkunde. 50(9). 678–682. 12 indexed citations
13.
Grischke, Eva‐Maria, Max Kaufmann, & W. Schmidt. (1989). Funktionelle Störungen des unteren Harntraktes nach Primärbehandlung bei Collum- und Corpus-Karzinom. Archives of Gynecology and Obstetrics. 245(1-4). 771–772. 1 indexed citations
14.
Kiesel, Ludwig, et al.. (1988). GnRH-Rezeptoren im menschlichen Mammakarzinomgewebe. Geburtshilfe und Frauenheilkunde. 48(6). 420–424. 6 indexed citations
15.
Kühn, W, et al.. (1987). Morphologische Prognosekriterien und klinischer Verlauf bei Ovarialtumoren vom »Borderline-Typ«. Geburtshilfe und Frauenheilkunde. 47(3). 173–178. 3 indexed citations
16.
Kühn, W, et al.. (1987). Klinischer Verlauf des Ovarialkarzinoms in Abhängigkeit von morphologischen Prognosefaktoren und zellkinetischen Parametern. Geburtshilfe und Frauenheilkunde. 47(7). 446–451. 4 indexed citations
17.
Kaufmann, Max, et al.. (1986). Distribution of intrapleural and intravenous Corynebacterium parvum in humans; 99mTc?, and 131I-labeled bacteria. Cancer Immunology Immunotherapy. 22(1). 56–61. 3 indexed citations
18.
Kaufmann, Max, et al.. (1977). Immunomorphological lymph node changes in patients with operable bronchogenic squamous cell carcinoma. Cancer. 39(6). 2371–2377. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Vijay K. Ulaganathan Breakdown of academic impact, for papers by C.D. Dijkstra Breakdown of academic impact, for papers by Sunny Malhotra Breakdown of academic impact, for papers by Carolyn J. Hoban Breakdown of academic impact, for papers by Friederike Frommer Breakdown of academic impact, for papers by Ben J. E. Raveney Breakdown of academic impact, for papers by Megumi Nakanishi Breakdown of academic impact, for papers by Kirsten Adlard Breakdown of academic impact, for papers by Karim L. Kreft Breakdown of academic impact, for papers by Elise Tran
Rankless by CCL
2026